Amgen (AMGN) Other Operating Expenses (2009 - 2026)

Amgen has reported Other Operating Expenses for 18 years, with the latest figure at $2.6 billion in Q1 2026.

• For the quarter ending Q1 2026, Other Operating Expenses fell 30.73% year-over-year to $2.6 billion; the trailing twelve-month figure through Mar 2026 stood at $12.2 billion (down 10.42% YoY), and the FY2025 full-year result was $13.3 billion, up 1.85% from the prior year.
• Other Operating Expenses for Q1 2026 stood at $2.6 billion, down from $3.1 billion in the prior quarter.
• The five-year high for Other Operating Expenses was $3.8 billion in Q1 2025, with the low at $1.6 billion in Q1 2022.
• Average Other Operating Expenses over 5 years is $2.7 billion, with a median of $3.1 billion recorded in 2025.
• Year-over-year, Other Operating Expenses tumbled 36.51% in 2022 and jumped 81.96% in 2023.
• Tracing AMGN's Other Operating Expenses over 5 years: stood at $1.7 billion in 2022, then jumped by 81.96% to $3.1 billion in 2023, then grew by 1.8% to $3.2 billion in 2024, then declined by 3.81% to $3.1 billion in 2025, then retreated by 13.79% to $2.6 billion in 2026.
• The last three Other Operating Expenses figures came in at $2.6 billion (Q1 2026), $3.1 billion (Q4 2025), and $3.4 billion (Q3 2025), per Business Quant data.

Peer Comparison